PETS AND CANCER

Nikki Rynia

Living with pets when living with cancer. For many people, pets feel like a part of the family. After a cancer diagnosis, pets can offer many benefits. There are some things to keep in mind when it

Pancare Foundation Annual Review 2021

Nikki Rynia

Pancare Foundation is proud to publish our Annual Review, highlighting our achievements of the 2020/21 financial year. Despite the ongoing COVID-19 pandemic presenting us with additional challenges,

Wins for pancreatic cancer clinical trials research

Nikki Rynia

Pancare is delighted to have contributed to two successfully funded clinical trials for pancreatic cancer research, announced in the recent 2021 MRFF Rare Cancers and Unmet Need (RCRDUN) Clinical

Advent Security forge new partnership with Pancare Foundation

Nikki Rynia

The tragic loss of a number of the Advent Security team’s close friends and family members to upper GI cancers resulted in the development of a formal partnership between Advent Security and

A message of thanks 2021 from CEO, Doug Hawkins

Nikki Rynia

As we approach the end of another year disrupted by the COVID-19 pandemic, I reflect on what has been a resounding theme for our Foundation and community – resilience in the face of adversity.

Critical new cancer research grant announced

Nikki Rynia

Pancare Foundation and Cancer Australia are pleased to announce successful applicants to the 2021 round of the Priority-driven Collaborative Cancer Research Scheme (PdCCRS).

New grant gives hope to Australians living with rare cancer

Nikki Rynia

Pancreatic and hepatobiliary surgeon, Dr Daniel Croagh has been awarded the Pancare Foundation-AGITG Cholangiocarcinoma Idea Generation Workshop Grant.

Coping with cancer during the holidays

Nikki Rynia

For those impacted by cancer, experiences of the festive season can induce a range of feelings. Some people will enjoy a time of celebration, for others it may be a difficult time of stress and

Pancare Foundation Holiday Office Hours

Nikki Rynia

We realise that the holidays can be a difficult time for many people, especially those impacted by an upper GI cancer. While our PanSupport team will be having a well-earned rest over the holiday

Recent study supports use of second line chemotherapy combined with active symptom control (ASC) for the treatment of advanced biliary tract cancer.

Nikki Rynia

Patients with advanced biliary tract cancer receiving second-line FOLFOX chemotherapy and active symptom control (ASC) are more than twice as likely to be alive at 12 months compared to those on ASC